A New Combination Haemophilus influenzae Type B and Neisseria meningitidis Serogroup C-Tetanus Toxoid Conjugate Vaccine for Primary Immunization of Infants
- 1 November 2007
- journal article
- research article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 26 (11) , 1057-1059
- https://doi.org/10.1097/inf.0b013e31813429fa
Abstract
We conducted a phase 3 randomized controlled trial looking at the immunogenicity and safety of a novel combined Haemophilus influenzae type b and Neisseria meningitidis serogroup C tetanus toxoid conjugate vaccine, Hib-MenC-TT in a 2-, 3-, and 4-month primary infant immunization schedule. SBA MenC titers > or =1:8 and anti-PRP concentrations > or =0.15 microg/mL were measured in 99.2% and 100%, respectively, of the infants receiving Hib-MenC-TT.Keywords
This publication has 12 references indexed in Scilit:
- Immunogenicity, Reactogenicity, and Immune Memory after Primary Vaccination with a Novel Haemophilus influenzae - Neisseria meningitidis Serogroup C Conjugate VaccineClinical and Vaccine Immunology, 2007
- Evaluation of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b vaccine given concurrently with meningococcal group C conjugate vaccine at 2, 3 and 4 months of ageArchives of Disease in Childhood, 2007
- Four and One-Half-Year Follow-up of the Effectiveness of Diphtheria-Tetanus Toxoids-Acellular Pertussis/Haemophilus influenzae Type b and Diphtheria-Tetanus Toxoids-Acellular Pertussis-Inactivated Poliovirus/H. influenzae Type b Combination Vaccines in GermanyThe Pediatric Infectious Disease Journal, 2004
- Haemophilus influenzae type b conjugate vaccinesImmunology, 2004
- Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introductionThe Lancet, 2004
- Validation of Serological Correlate of Protection for Meningococcal C Conjugate Vaccine by Using Efficacy Estimates from Postlicensure Surveillance in EnglandClinical and Vaccine Immunology, 2003
- Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussisThe Lancet, 2003
- Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success storyVaccine, 2001
- Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussisThe Lancet, 1999
- The Protective Level of Serum Antibodies to the Capsular Polysaccharide of Haemophilus influenzae Type bThe Journal of Infectious Diseases, 1983